Targeting a specific enzyme to improve cancer treatment outcomes in breast cancer and melanoma
Targeting ATP-citrate lyase (ACLY) to overcome therapy resistance in breast cancer and melanoma
This study is looking at how a specific enzyme called ACLY affects breast cancer and melanoma, and it aims to see if blocking this enzyme can help make current treatments work better for patients who have developed resistance to them.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pace University New York NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10580197 on NIH RePORTER |
What this research studies
This research investigates the role of ATP-citrate lyase (ACLY) in breast cancer and melanoma, focusing on how cancer cells develop resistance to existing therapies. By inhibiting ACLY, which is linked to cancer cell metabolism and growth, the study aims to enhance the effectiveness of current treatments. The approach involves combining ACLY inhibitors with established therapies to potentially overcome resistance mechanisms that cancer cells use to evade treatment. Patients may be monitored for changes in tumor response and overall health as part of this innovative strategy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with breast cancer or melanoma who are experiencing treatment resistance.
Not a fit: Patients with early-stage cancer who have not yet undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with breast cancer and melanoma who have developed resistance to current therapies.
How similar studies have performed: Other research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach could be effective.
Where this research is happening
New York, United States
- Pace University New York — New York, United States (Active)
Researchers
- Principal investigator: Krucher, Nancy a — Pace University New York
- Study coordinator: Krucher, Nancy a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.